Characteristics, clinical findings, and treatment of idiopathic pulmonary fibrosis in Japanese patients registered with a medical subsidy system for intractable diseases
In approximately 90 % of patients, serum KL-6 and SP-D levels increased and the positive rate increased as the disease severity increased. Even patients with mild diseases experience challenges in transportation as well as pain, discomfort, anxiety, or depression.
Authors
- Hirotaka Nishikiori (ORCID: https://orcid.org/0000-0002-0573-9344)
- Koshi Nakamura (ORCID: https://orcid.org/0000-0001-8141-7614)
- Yasuhiro Kondoh (ORCID: https://orcid.org/0000-0001-7456-5459)
- Hirofumi Chiba (ORCID: https://orcid.org/0000-0002-7033-3084)
- Takafumi Suda (ORCID: https://orcid.org/0000-0001-5300-0504)
- Reoto Takei (ORCID: https://orcid.org/0000-0003-1698-2304)
Institutions
- Sapporo Medical University (JP)
- Hamamatsu University School of Medicine (JP)
- University of the Ryukyus (JP)
- Tosei General Hospital (JP)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1016/j.resinv.2025.04.008
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- AstraZeneca
- Boehringer Ingelheim
- Ministry of Health, Labour and Welfare